About BS Medical Technology (Nuclear Medicine Technology) at DIMT
The Department of Nuclear Medicine and Theranostics is dedicated to advancing precision oncology through excellence in diagnostic imaging, targeted therapies, education, and research.
As a key pillar of the Comprehensive Cancer Center, we integrate state-of-the-art technology with clinical expertise to deliver personalized care and improved patient outcomes. Our commitment extends beyond service delivery to shaping the future of nuclear medicine through innovation and knowledge generation.
- Provide comprehensive educational and clinical training opportunities in Nuclear Medicine Technology for allied healthcare professionals.
- Develop research capacity and promote the dissemination of emerging knowledge, skills, and technologies in nuclear medicine and theranostics.
- Deliver evidence-based, high-quality clinical practice in diagnostic imaging and radionuclide therapies to improve patient care.
- Foster interdisciplinary collaboration and professional skills among healthcare professionals, students, researchers, and the local community.
- Design and implement innovative projects in nuclear medicine, theranostics, and healthcare technology to support fiscal sustainability through collaboration with healthcare organizations, industries, and research institutions.
For many years, Dow University of Health Sciences (DUHS) has been a beacon of hope for cancer patients, providing state-of-the-art treatment options aimed at improving patient outcomes. The university’s unwavering commitment to this cause reached an important milestone with the inauguration of the Comprehensive Cancer Centre on April 16, 2025. This visionary project initiated by Professor Dr. Muhammad Saeed Quraishy (TI) former Vice Chancellor of DUHS, aims to deliver advanced cancer care that is both high-quality and affordable, housed under one roof to ensure accessibility for all.
The journey towards this goal began earnestly in October 2021 with the establishment of Pakistan’s first public sector Gamma Knife Radiosurgery unit. This was a pioneering step, marking DUHS’s commitment to adopting cutting-edge technologies for cancer treatment. In November 2022, the foundation stone was laid for the extension of civil work dedicated to the Comprehensive Cancer Centre, setting the stage for a holistic approach to cancer care.
The Comprehensive Cancer Centre itself is a meticulously designed ground plus two-story building. The ground floor hosts three major departments: Gamma Knife Stereotactic Radiosurgery with on-site MRI for precise planning, Radiation Therapy department equipped with Pakistan’s first MR- LINAC for precise radiation treatment of various cancers, and the newly launched Nuclear Medicine and Theranostics department. The first floor accommodates the Medical Oncology department, which is bolstered by an onco-pharmacy and surgical-oncology clinics. The second floor houses a large auditorium designated for in-house academic activities, underlining the university’s commitment to continuous learning and innovation.
Prof. Dr. Nosheen Fatima Director, Nuclear Medicine & Theranostics
Welcome to the Department of Nuclear Medicine and Theranostics.
It is a privilege to lead a department at the forefront of precision oncology and molecular imaging. With over two decades of clinical, research and academic experience, my vision is to establish a benchmark of excellence in Theranostics, innovation, and patient-centered care.
We integrate advanced PET/CT, hybrid molecular diagnostics, and targeted radionuclide therapies to deliver personalized, high-impact care. Alongside clinical excellence, we are committed to education, hands-on training, and fostering a culture of inquiry and collaboration.
Our strategy is firmly aligned with internationally recognized quality standards and accreditation frameworks, ensuring safety, consistency, and continuous improvement. We are also advancing AI-integrated research and translational collaborations to improve cancer outcomes, particularly within our population.
Aligned with the vision of DUHS, we are building a future-ready department focused on infrastructure development, service expansion, academic excellence, and equitable access to advanced care.
We remain committed to transforming care, advancing science, and improving lives, redefining precision oncology through innovation, leadership, and impact.
The Department of Nuclear Medicine and Theranostics is committed to advancing precision oncology through excellence in diagnostic imaging, targeted radionuclide therapy, education, and research.
Aligned with DUHS’s vision of transforming and saving lives, we deliver patient-centered care supported by cutting-edge technology and innovation. As part of the Comprehensive Cancer Center, we strive to be a nationally recognized hub of excellence in molecular imaging and Theranostics.
Our 2026–2029 strategic focus includes strengthening infrastructure, expanding clinical services, advancing academic programs, and promoting impactful research-while ensuring equitable access to high-quality nuclear medicine care.
- HEC
- PMDC
- CPSP
- AHPC
Admission Process
Every stage of our admissions process is aimed at identifying the aspects of your academic trajectory and personal ambitions
Your Career Starts Here!
Program Highlights
Duration
4 years
Curriculum
Seats
The program contains 25 seats per year in total.
Contact Us
DOW INSTITUTE OF MEDICAL TECHNOLOGY (DIMT)